GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (STU:B9A) » Definitions » Gross-Profit-to-Asset %

BioArctic AB (STU:B9A) Gross-Profit-to-Asset % : 9.38% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is BioArctic AB Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. BioArctic AB's annualized Gross Profit for the quarter that ended in Mar. 2024 was €9.68 Mil. BioArctic AB's average Total Assets over the quarter that ended in Mar. 2024 was €103.22 Mil. Therefore, BioArctic AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 9.38%.


BioArctic AB Gross-Profit-to-Asset % Historical Data

The historical data trend for BioArctic AB's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB Gross-Profit-to-Asset % Chart

BioArctic AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only 16.08 1.10 -3.26 16.93 51.12

BioArctic AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 149.49 -4.48 66.00 -5.92 9.38

Competitive Comparison of BioArctic AB's Gross-Profit-to-Asset %

For the Biotechnology subindustry, BioArctic AB's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioArctic AB's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioArctic AB's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where BioArctic AB's Gross-Profit-to-Asset % falls into.



BioArctic AB Gross-Profit-to-Asset % Calculation

BioArctic AB's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=47.056/( (78.073+106.032)/ 2 )
=47.056/92.0525
=51.12 %

BioArctic AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=9.684/( (106.032+100.413)/ 2 )
=9.684/103.2225
=9.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


BioArctic AB Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of BioArctic AB's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioArctic AB (STU:B9A) Business Description

Traded in Other Exchanges
Address
Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB (STU:B9A) Headlines

No Headlines